INBX
Inhibrx Biosciences, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-19
Figures on this page computed 2026-11-08 12:48 UTC
Last close
86.76USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-19
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002007919-26-000006
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-19
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002007919-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-03-19
- 10-K for 2025, filed 2026-03-19
- 10-K for 2025, filed 2026-03-19
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-19
- 10-Q for 2025, filed 2026-08-13
-10773.5%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002007919-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-03-19
- 10-K for 2025, filed 2026-03-19
-9986.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002007919-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-03-19
- 10-K for 2025, filed 2026-03-19
13.39Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002007919-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-03-19
- 10-Q for 2025, filed 2026-08-13
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.08 against 0.50 on the market's range.
- Growth-36.7%8 of 100, below its sector
- Returns on capital-1752.2%3 of 100, below its sector
- Margins-10386.5%2 of 100, below its sector
- Price163.8x0 of 100, below its sector
- Safety13.3939 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9What it sells
1Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
1 segments, 0 places and 0 named customers, each as the filer published it.
1 segments, 0 places and 0 named customers, each as the filer published it.
Every figure in this lens
Reportable Segment1,300,00010-K for 2025, filed 2026-03-19
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0002007919-26-000006
- Reported in
- USD